Table of Contents
Preface ix
How Not to Kill the Patient-or the Investigator ix
Why Read This Book? A View from the Trenches ix
Acknowledgments xiii
Introduction xv
Chapter 1 Overview 3
Why do Studies? 3
Liability? 4
Jargon 5
Who's Who 5
Study Activities 10
Phases of Drug Development 10
Protocol Design Part 1: Parts of a Protocol 16
Protocol Design Part 2: Patient Mix 18
Product Quality: Seals of Approval 19
Protocol Design Part 3: Mixing the Ingredients 20
Medical Device Trials 22
Vaccines and Other Biologics 28
The Evolution of U.S. Drug Law 38
Problems with Antibiotics 41
Conclusion 43
Chapter 2 Scrounging Your First Study 45
What do You Need to Get Started? 45
Navigating Site Selection: Landing your First Study 48
Newer Methods for Landing a Study 49
Why It's so Difficult to Get Studies 53
Site Selection: Be Careful What you Wish for-you Might Get it 55
Site Selection: Why a Site is Chosen, or a Marriage of Convenience 57
Site Qualification Visit, or "Shall we Dance?" 59
Do Size and Setting Matter? 62
Conclusion 65
Chapter 3 Reality Testing: Feasibility, Budgets, and Contracts 67
Feasibility Overview 67
Protocol Feasibility 68
Patient Pool 72
Staffing 73
Regulatory Considerations: IRBs 76
Managing the IRB Submission Process 78
Regulatory Considerations: Billing for Clinical Trials 80
Antikickback, False Claims, and Stark Laws 82
Budget Feasibility 83
CROs and SMOs-Dealing with the Middleman 97
Contract Basics 100
The Dark Side of Contracts, or Things you Mother Never Told you 109
Win-Win Relationships 110
Conclusion 112
Chapter 4 Regulatory Issues 113
New Regulations 115
Form FDA 1572-What are you Really Signing? 121
IRBs 123
HIPAA 125
Drug Accountability 129
Financial Disclosure, or Whose Business is it Anyway? 130
Audits 132
How to Prepare for an Audit 143
Conclusion 145
Chapter 5 Study Start-Up 147
Informed Consent: Safe, Sane, and Consensual 147
Start-Up in Theory 157
Start-Up in Practice: The Paper Trail-Implementing Regulatory Details 159
Initiation Visit 160
Electronic Medical Records 161
Volunteer Recruitment Strategies 164
Advertising 170
Web Advertising and Social Networking 175
Approaching the Patient, or "you Want me to do What?" 178
Conclusion 180
Chapter 6 Study Activities: Strategies and Tools 181
SOPS-Why Bother? 181
Study Tracking: What Day is Today? 185
General Tracking Procedures 185
Worksheets, Forms, and Study Folders: Getting in Touch with your Inner OCD 186
Project Management Techniques 189
Software Programs 189
Coping with Minutiae 190
Billing Compliance-Practicalities 191
Drug Storage and Accountability 192
Maintaining Drug and Supply Inventories 193
Monitoring Visits 194
Volunteer Retention and Satisfaction 195
Patient Instructions 198
The Paper Trail Continues 202
Study Closing 213
Conclusion 216
Chapter 7 Perspective on the State of the Industry 217
Costs of Clinical Trials 217
"Breaking the Scientific Bottleneck" 225
Where have all the Trials Gone? 237
Overseas Drug Manufacturing 241
Conclusion 242
Chapter 8 Ethical Issues in Human Subjects Research 243
Historical Context 244
Ethical Principles (the Belmont Report) 248
Special Populations 255
Individual Research Practice: The Nature of the Beast 258
Financial Pressure and Conflict of Interest 258
Whose Body is it? Tissue Ownership 265
Patient-Prompted Ethical Issues 270
Adverse Events: Related Ethical Issues 271
Publication Ethics 275
Practice Guidelines 277
Off-Label Uses 278
IRB-Related Ethical Issues 279
Unanticipated Risk in Clinical Trials 281
Who's Minding the Store? A Case Study 286
Conclusion 290
Chapter 9 Society and Politics 293
Politics of Research: The FDA 293
Politics of Research: Women 300
Politics of Research: Religion 307
Politics of Research: Race 311
Politics of Research: Race and Gender Overlap 313
Politics of Research: Shifting Studies to Developing Countries 315
Justice and Societal Needs 324
Conclusion 336
Chapter 10 Opportunities and Training in Clinical Research 337
Enhancing your Practice 338
Brief Training Options 339
Formal Training Programs 341
Conclusion 344
Epilogue 345
Appendix A Background Resource Information 349
Appendix B Suggested Resources 387
Appendix C Career Information and Training Programs 401
Notes 443
Glossary and Acronym Guide 511
Bibliography 525
Index 579
About the Author 601